Press Releases

Aug 04, 2023
Aceragen, Inc. to Delist from The Nasdaq Stock Market Read More
May 30, 2023
Aceragen, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q Filing Read More
Feb 06, 2023
Aceragen Announces Recommendation of Data Monitoring Committee in Terra Study Read More
Jan 17, 2023
Idera Pharmaceuticals Announces Name Change to Aceragen, Inc. and Provides Near-Term Strategic Outlook Read More